Muzsik, Agata Bajerska, Joanna Jeleń, Henryk H Walkowiak, Jarosław Krzyżanowska-Jankowska, Patrycja Chmurzynska, Agata
Published in
Menopause (New York, N.Y.)
In the present study, we tested whether calorie-restricted diets differing in their percentage of energy derived from monounsaturated fatty acids and carbohydrates can affect the metabolism of fatty acids (FAs) in postmenopausal women. Moreover, we examined whether polymorphisms of FADS1 and FADS2 are associated with these changes. Postmenopausal w...
Schnall, Rebecca Liu, Jianfang Reame, Nancy
Published in
Menopause (New York, N.Y.)
To what extent menopause is related to symptom burden in women living with HIV (WLWH) is unclear, as a specific reproductive health analysis has seldom been undertaken, in part due to an inadequate assessment of reproductive status. The purpose of this study was to document and compare symptom frequency and attribution over 46 days and examine diff...
Hedlin, Haley Weitlauf, Julie Crandall, Carolyn J Nassir, Rami Cauley, Jane A Garcia, Lorena Brunner, Robert Robinson, Jennifer Stefanick, Marica L Robbins, John
...
Published in
Menopause (New York, N.Y.)
The aim of the study was to develop a web-based calculator that predicts the likelihood of experiencing multiple, competing outcomes prospectively over 5, 10, and 15 years. Baseline demographic and medical data from a healthy and racially and ethnically diverse cohort of 161,808 postmenopausal women, aged 50 to 79 at study baseline, who participate...
Donzelli, Alberto Castelluzzo, Gianluca
Published in
Menopause (New York, N.Y.)
Brislane, Áine Low, David A Carter, Sophie E Holder, Sophie M Jones, Helen Hopkins, Nicola D
Published in
Menopause (New York, N.Y.)
Menopause is associated with lower peripheral vascular function; however, cerebrovascular responses to this time-period are unclear. We aimed to describe peripheral vascular and cerebrovascular differences between pre- and postmenopausal women. Fifty pre- and postmenopausal women (N = 100) underwent assessments of cerebral blood flow; cerebrovascul...
Andany, Nisha Kaida, Angela de Pokomandy, Alexandra Yudin, Mark H Wang, Lu Kennedy, V Logan Webster, Kath Loutfy, Mona
Published in
Menopause (New York, N.Y.)
Menopause is a pivotal transition for women. Previous studies have suggested increased risk of early menopause (40-45 years) and premature menopause (
Moyneur, Erick Dea, Katherine Derogatis, Leonard R Vekeman, Francis Dury, Alain Y Labrie, Fernand
Published in
Menopause (New York, N.Y.)
To quantify the association between vulvovaginal atrophy and depression, major depressive disorder, and anxiety. Women with vulvovaginal atrophy from the Truven Health MarketScan Commercial and Medicare Supplemental Databases (01/2010-09/2016) with ≥365 days of continuous insurance coverage before and after the first vulvovaginal atrophy/dyspareuni...
Perri, Tamar Farhadian, Yasmin Friedman, Eitan Korach, Jacob
Published in
Menopause (New York, N.Y.)
BRCA-mutation carriers are offered risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 35 to 40 years, leading to major life-quality and health-related issues associated with early menopause. Hormone therapy (HT) may significantly alleviate menopausal symptoms without increasing breast or ovarian cancer risk in BRCA carriers. We investigat...
Taguchi, Akira Shiraki, Masataka Tanaka, Satoshi Ohshige, Hideyo Nakamura, Toshitaka
Published in
Menopause (New York, N.Y.)
This randomized, clinical trial investigated whether zoledronic acid combined with oral health maintenance can improve periodontal disease associated with osteoporosis, thus reducing the risk of tooth loss. Participants were those of the ZONE (ZOledroNate treatment in efficacy to osteoporosis) study. None of the participants had symptomatic periodo...
Geiger, Paul J Eisenlohr-Moul, Tory Gordon, Jennifer L Rubinow, David R Girdler, Susan S
Published in
Menopause (New York, N.Y.)
The aim of this study was to determine the efficacy of transdermal estradiol (E2) plus intermittent progesterone (EPT) for improving self-reported sleep in perimenopausal women, after controlling for vasomotor symptoms (VMS) bother and depressive symptoms. Using a double-blind, placebo-controlled design, 172 healthy women meeting STRAW+10 criteria ...
